Aardsma well-armed ; He's got pitches, must add control

The Boston Globe | April 15, 2008| | Copyright

CLEVELAND - David Aardsma was one of the best relievers in baseball to start last season. With the White Sox, Aardsma came into games and quite often dominated. His fastball would reach about 96 miles per hour, plus he had (and still has) good secondary pitches. By May 12, after working 20 2/3 innings, Aardsma had struck out 26, allowed 3 runs, and amassed a 1.31 ERA.

Then it started going bad. Very bad. Over his next eight games, Aardsma allowed 16 runs and struck out just six in seven innings. He allowed 16 hits, six walks, and three home runs as his ERA ballooned to 20.57 over the span. ...

Read all of this article with a FREE trial to HighBeam Research

Related newspaper, magazine, and trade journal articles from HighBeam Research

(Including press releases, facts, information, and biographies)

Chiron Announces it will Expand Senior Management by Recruiting New Chief Executive Officer.
Business Wire ; ...BW HealthWire)--Jan. 29, 1997--Chiron Corporation (NASDAQ:CHIR) announced...president and chief executive officer. Chiron's current president and chief executive...then will become vice chairman of the Chiron Board of Directors, and his commercial...
Chiron and Ciba-Geigy form unique global partnership in biotechnology; Ciba to hold 49.9% interest in Chiron following tender offer for 11.9 million shares at $117 per share and exchange of vaccines, diagnostics interests for new Chiron shares; total consideration is $2.1 billion; World center of biotech excellence and leading global health care company join complementary strengths and expand R&D collaboration; Chiron to continue to operate. (hiron to continue to operate.)
Business Wire ; ...Dr. William Rutter, Chairman of Chiron Corporation (NASDAQ:CHIR), and Dr...to form a strategic partnership between Chiron and Ciba. The partnership involves a...Ciba in a collaborative relationship, Chiron will continue to operate independently...
Chiron and Viagene Reach Agreement for Gene Therapy Strategic Merger.
Business Wire ; ...BUSINESS WIRE)--April 24, 1995--Chiron Corporation (NASDAQ:CHIR) and Viagene...effect a strategic merger that would enable Chiron to achieve synergies of the gene therapy...companies. Under terms of the agreement, Chiron will acquire the outstanding common shares...
Chiron to Acquire PowderJect.
PR Newswire ; -- Strategic Fit Enhances Chiron's Stature in Global Vaccines Business...May 19 /PRNewswire-FirstCall/ -- Chiron Corporation today announced that it...company PowderJect Pharmaceuticals plc. Chiron has offered PowderJect 550 pence per...
Chiron and Ciba to Collaborate on Combinatorial Chemistry-Based Research and Development.
Business Wire ; ...BUSINESS WIRE)--Nov. 28, 1995--Chiron Corp. (NASDAQ:CHIR) and Ciba-Geigy...discovery research and development using Chiron's combinatorial chemistry technology...exclusive, perpetual license to apply Chiron's combinatorial chemistry technologies...
Chiron Recalls, Withdraws Morupar Vaccine
News Wire article from: AP Online ; ...16-2006 Dateline: SAN FRANCISCO The Chiron life sciences center is seen Feb. 25...in an Emeryville, Calif. file photo. Chiron Corporation today announced that it is...rubella (MMR) vaccine, MORUPAR(R). Chiron supplied approximately 5 million doses...
Chiron Recalls and Withdraws MORUPAR(R) MMR Vaccine from Italian and Developing World Markets -- Chiron Also Revises 2005 Adjusted EPS From $1.34 to $1.31 Per Share and GAAP EPS From $0.97 to $0.94 Per Share.
Business Wire ; EMERYVILLE, Calif. -- Chiron Corporation (NASDAQ: CHIR) today...rubella (MMR) vaccine, MORUPAR(R). Chiron supplied approximately 5 million doses...indicate that adverse events remain rare, Chiron is recalling and withdrawing the vaccine...
Chiron agrees to buyout Novartis paying $5.1 billion
Newspaper article from: Oakland Tribune ; Bay Area biotechnology giant Chiron Corp. agreed Monday to hand over its...take control of Emeryville-based Chiron to get a hand in the vaccine market...analysts with Lehman Brothers predict. "Chiron's non-Novartis directors have unanimously...
CHIRON LICENSES ITS HIV-1 AND HCV INTELLECTUAL PROPERTY FOR NAT BLOOD SCREENING TO ROCHE.
PR Newswire ; ...to be Supplied to Blood Bank Market By Both Chiron and Roche PR Newswire, London, May 23. This press release is transmitted on behalf of Chiron Corporation Emeryville, California - Chiron Corporation (Nasdaq: CHIR) announced today...
Chiron announces management changes including appointing Pablo Valenzuela president of Chiron Diagnostics.
Business Wire ; ...BUSINESS WIRE)--April 17, 1995--Chiron Corporation (NASDAQ:CHIR) announced today...senior vice president and a co-founder of Chiron, has been named president, Chiron Diagnostics, with responsibility for infectious...

Find more facts and information related to the article "Aardsma well-armed ; He's got pitches, must add ..."